Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    Menopause Hormone Therapy: Evidence-Based Recommendations and Practices
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Global Call for Collaborators – Pfizer Migraine Research
    Release Date:
    Review Process: Pfizer Internal
    Research Internal Medicine All
    Improving care in headache medicine and the management of migraine
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Israel
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    COVID-19 Epidemiology Research
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Algeria, Egypt, Indonesia, Lebanon, Philippines, Thailand, Tunisia, Vietnam
    Latin America Needs Assessment of Mental Health
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Mayo Clinic
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation: Spanish (link)
    Translation: Mandarin (link)
    Translation: Arabic (link)
    Quality Improvement Rare Disease All
    Identifying and Diagnosing Juvenile Idiopathic Arthritis (JIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Antibiotic Stewardship in Pediatrics
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
    China Educational Needs Assessment in Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China
    China Medical Education in Atopic Dermatitis Awareness and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China
    Educational Activities to Improve Vaccination Rate beyond Clinical Departments
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology All
    Promoting Pain Treatment in Osteoarthritis Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improve the Treatment Environment for Cancer Pain Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improving the Knowledge Gap on Vaccine Safety Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan